fMRI of Eye Movement Phenotype in Schizophrenia
精神分裂症眼动表型的功能磁共振成像
基本信息
- 批准号:7340477
- 负责人:
- 金额:$ 18.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-01 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntipsychotic AgentsAreaBehavioralBiologicalBiologyBrainBrain regionCerebellar vermis structureCerebellumDataDiseaseDrug usageEtiologyExhibitsEye MovementsFamilyFigs - dietaryFire - disastersFunctional Magnetic Resonance ImagingGeneticGoalsImageImpairmentKnowledgeLeadMagnetic Resonance ImagingMaintenanceMeasuresMethodsModelingMolecular GeneticsMorphologic artifactsMotionMotorMovementNeuronsParietal LobePathway interactionsPatientsPatternPerformancePharmaceutical PreparationsPhenotypeProcessPsychotic DisordersPublished CommentRelative (related person)RelianceReportingResearchResearch PersonnelRetinaRetinalSchizophreniaSecondary toSensorySiblingsSignal TransductionSmooth PursuitSymptomsTemporal LobeTestingTranslatingVisual Fieldsbaseblood oxygen level dependentdesignfrontal eye fieldsimprovedinsightneural circuitneuromechanismneurophysiologyoculomotorpredictive pursuitprobandprogramsrelating to nervous systemresponsetrait
项目摘要
DESCRIPTION (provided by applicant): The etiopathophysiology of schizophrenia is incompletely understood. Evidence supports an association between genetic liability for schizophrenia and smooth pursuit eye movement (SPEM) abnormalities, and it has been suggested that SPEM can serve as a phenotype in molecular genetic studies. However, the neural basis of reported abnormalities in SPEM is not well understood, and even less is known about how genetic effects are translated into aberrant neural circuit controlling SPEM. Knowledge of the biological mechanisms underlying SPEM abnormalities and their relationship to the schizophrenia phenotype may provide critical insights into the etiology of this disease. The goal of the proposed research is to combine functional magnetic resonance imaging (fMRI) and SPEM measures to study 1) the underlying neural mechanism of schizophrenia-related SPEM impairments; and 2) the degree to which pursuit-related imaging changes aggregate in families. We have behaviorally modeled the relative contributions of retinal motion and extraretinal motion signals to smooth pursuit maintenance in healthy subjects and in relatives of schizophrenia patients. The results indicate that performance in healthy subjects depends primarily on the predictive, or extraretinal motion input, while relatives of schizophrenia patients show deficits in this component of the pursuit response. This deficit may lead to an increased reliance on the immediate, retinal motion sensory input to maintain smooth pursuit. We hypothesize that this pattern of behavioral abnormality has a neurophysiological basis that will be detectable in fMRI imaging signal as reduced activation in the extraretinal motion processing pathway accompanied by a compensatory increase in activation in regions responsible for retinal motion processing. We further hypothesize that this pattern of neural activity will be present in the clinically unaffected siblings of affected probands, supporting a genetic influence on the neural circuit controlling predictive smooth pursuit deficit in schizophrenia.
描述(由申请人提供):精神分裂症的发病生理学尚不完全清楚。证据支持精神分裂症的遗传倾向与平滑追求眼动(SPEM)异常之间的关联,并且已经表明SPEM可以作为分子遗传学研究中的一种表型。然而,所报道的SPEM异常的神经基础尚不清楚,更不清楚遗传效应如何转化为控制SPEM的异常神经回路。了解SPEM异常的生物学机制及其与精神分裂症表型的关系可能为该病的病因学提供重要的见解。本研究的目的是将功能磁共振成像(fMRI)和SPEM测量相结合,研究1)精神分裂症相关SPEM损伤的潜在神经机制;2)与追求相关的影像变化在家庭中聚集的程度。我们在健康受试者和精神分裂症患者亲属中建立了视网膜运动和视网膜外运动信号对平滑追求维持的相对贡献的行为模型。结果表明,健康受试者的表现主要取决于预测或视网膜外运动输入,而精神分裂症患者的亲属在这部分的追求反应中表现出缺陷。这种缺陷可能导致对即时视网膜运动感官输入的依赖增加,以维持平滑的追求。我们假设这种行为异常模式具有神经生理学基础,在fMRI成像信号中可以检测到视网膜外运动处理通路的激活减少伴随着视网膜运动处理区域的代偿性激活增加。我们进一步假设,这种神经活动模式将出现在受影响先证的临床未受影响的兄弟姐妹中,支持遗传影响控制精神分裂症预测平滑追求缺陷的神经回路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
L Elliot Elliot Hong其他文献
L Elliot Elliot Hong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('L Elliot Elliot Hong', 18)}}的其他基金
Towards Multisystem-Brain Successful Aging in Schizophrenia Spectrum
精神分裂症谱系迈向多系统大脑成功衰老
- 批准号:
9752660 - 财政年份:2018
- 资助金额:
$ 18.23万 - 项目类别:
Towards Multisystem-Brain Successful Aging in Schizophrenia Spectrum
精神分裂症谱系迈向多系统大脑成功衰老
- 批准号:
10392882 - 财政年份:2018
- 资助金额:
$ 18.23万 - 项目类别:
Towards Multisystem-Brain Successful Aging in Schizophrenia Spectrum
精神分裂症谱系迈向多系统大脑成功衰老
- 批准号:
9922360 - 财政年份:2018
- 资助金额:
$ 18.23万 - 项目类别:
The Role of Stress-Immune-Connectome Disruption in Mechanisms of Chinese Early Schizophrenia Spectrum
应激-免疫-连接体破坏在中国早期精神分裂症谱系机制中的作用
- 批准号:
10057388 - 财政年份:2017
- 资助金额:
$ 18.23万 - 项目类别:
Genetics to Brain Biomarkers in Kynurenine Pathway Dysfunction
犬尿氨酸通路功能障碍的脑生物标志物的遗传学
- 批准号:
10661740 - 财政年份:2014
- 资助金额:
$ 18.23万 - 项目类别:
Genetics to Brain Biomarkers in Kynurenine Pathway Dysfunction
犬尿氨酸通路功能障碍的脑生物标志物的遗传学
- 批准号:
10425363 - 财政年份:2014
- 资助金额:
$ 18.23万 - 项目类别:
Genetics to Brain Biomarkers in Kynurenine Pathway Dysfunction
犬尿氨酸通路功能障碍的脑生物标志物的遗传学
- 批准号:
10016396 - 财政年份:2014
- 资助金额:
$ 18.23万 - 项目类别:
Genetics to Brain Biomarkers in Kynurenine Pathway Dysfunction
犬尿氨酸通路功能障碍的脑生物标志物的遗传学
- 批准号:
10218011 - 财政年份:2014
- 资助金额:
$ 18.23万 - 项目类别:
相似海外基金
Drug Interactions Involving Second-generation Antipsychotic Agents Leading to Sudden Cardiac Arrest
涉及第二代抗精神病药物的药物相互作用导致心脏骤停
- 批准号:
10661090 - 财政年份:2022
- 资助金额:
$ 18.23万 - 项目类别:
Drug Interactions Involving Second-generation Antipsychotic Agents Leading to Sudden Cardiac Arrest
涉及第二代抗精神病药物的药物相互作用导致心脏骤停
- 批准号:
10501196 - 财政年份:2022
- 资助金额:
$ 18.23万 - 项目类别:
Possible mechanism of action of metabolic syndrome induction in patients treated with atypical antipsychotic agents
使用非典型抗精神病药物治疗的患者诱导代谢综合征的可能作用机制
- 批准号:
22590157 - 财政年份:2010
- 资助金额:
$ 18.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The use of atypical antipsychotic agents and the risk of breast cancer
非典型抗精神病药物的使用和乳腺癌的风险
- 批准号:
192724 - 财政年份:2009
- 资助金额:
$ 18.23万 - 项目类别:
Operating Grants
Indolobenzox- and Thiazepines as Atypical Antipsychotic Agents
吲哚苯氧和硫氮卓类药物作为非典型抗精神病药
- 批准号:
7539253 - 财政年份:2008
- 资助金额:
$ 18.23万 - 项目类别:
Ectopic activators of M1 as novel antipsychotic agents
M1 异位激活剂作为新型抗精神病药物
- 批准号:
7676049 - 财政年份:2007
- 资助金额:
$ 18.23万 - 项目类别:
Ectopic activators of M1 as novel antipsychotic agents
M1 异位激活剂作为新型抗精神病药物
- 批准号:
7626881 - 财政年份:2007
- 资助金额:
$ 18.23万 - 项目类别:
Ectopic activators of M1 as novel antipsychotic agents
M1 异位激活剂作为新型抗精神病药物
- 批准号:
7333930 - 财政年份:2007
- 资助金额:
$ 18.23万 - 项目类别:
Muscarinic receptor activators as antipsychotic agents
作为抗精神病药物的毒蕈碱受体激活剂
- 批准号:
7034693 - 财政年份:2006
- 资助金额:
$ 18.23万 - 项目类别:
Muscarinic receptor activators as novel antipsychotic agents
毒蕈碱受体激活剂作为新型抗精神病药
- 批准号:
7163800 - 财政年份:2006
- 资助金额:
$ 18.23万 - 项目类别:














{{item.name}}会员




